Health Catalyst Plans to Announce Q2 2025 Results
Health Catalyst, Inc. (Nasdaq: HCAT), a frontrunner in data and analytics technology for healthcare organizations, is gearing up to release its operating results for the second quarter of 2025. The announcement is slated for a Thursday, following the market's closure on the specified date. This event is significant for investors and stakeholders as it provides insights into the company's performance and strategic direction.
Details of the Conference Call
Following the release of the results, Health Catalyst will hold a pivotal conference call at 5:00 PM ET. Participants interested in this call can join by dialing 800-343-5172 for those located in the U.S. Alternatively, international participants can reach the call at 203-518-9856. Ensure to reference the conference ID “HCATQ225” when prompted. For those who prefer digital engagement, a live audio webcast will be accessible shortly after the results are unveiled. This webcast will be a wonderful resource for those wanting to follow the highlights of the call.
Webcast Replay Access
Can't attend the call live? No worries! A replay of the conference call will be made available shortly after it concludes, providing an on-demand listening experience. This will remain accessible for approximately 90 days, ensuring ample time for all interested parties to catch up on the valuable information shared.
About Health Catalyst
Health Catalyst (Nasdaq: HCAT) stands out in the healthcare tech landscape with its innovative data and analytics solutions. With the aim to drive smarter healthcare, the company supports over a thousand organizations globally, enabling measurable clinical, financial, and operational improvements across complex healthcare ecosystems. Its robust technology ecosystem, known as Health Catalyst Ignite™, is designed to empower organizations with AI-driven data solutions and expert services. These offerings translate hefty volumes of patient information into actionable insights, ultimately guiding healthcare professionals to make informed decisions.
Driving Meaningful Change
At the core of Health Catalyst's mission is the commitment to operational excellence. The company has been integral in generating billions of dollars in measurable results, showcasing its capability to ignite substantial healthcare advancements through data-informed strategies. By maintaining high-value data standards and healthcare expertise, Health Catalyst enables organizations to navigate the intricate landscape of healthcare data effectively.
Investor Relations at Health Catalyst
If you have questions or need further information regarding Health Catalyst, the Investor Relations team is ready to assist you. Jack Knight, the Vice President of Investor Relations, can be reached at +1 (855) 309-6800. The team is dedicated to facilitating clear communication with investors and ensuring they are well-informed about the company's direction and performance.
Media Inquiries
For those looking to connect with the media department, Kathryn Mykleseth serves as the Director of Public Relations and Communications at Health Catalyst. She is available for any media-related queries, showcasing the company’s commitment to transparent communication within the media landscape.
Frequently Asked Questions
What are Health Catalyst's upcoming operating results?
Health Catalyst is set to announce its second quarter 2025 operating results on Thursday following the market's close.
How can I participate in the conference call?
Participants can join the conference call by dialing 800-343-5172 or 203-518-9856 and using the conference ID “HCATQ225.”
Will there be a replay of the conference call?
Yes, a replay will be accessible shortly after the live call concludes and will remain available for around 90 days.
What services does Health Catalyst provide?
Health Catalyst provides data and analytics technology and services that enhance healthcare outcomes through actionable insights and effective data usage.
Who can I contact for investor relations inquiries?
For investor relations, you can contact Jack Knight, the Vice President of Investor Relations, at +1 (855) 309-6800.
